T&iacute;tulo original: Transcatheter Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis Using a Repositionable Valve System. 30-Day Primary Endpoint Results From the REPRISE II Study. Referencia: Ian T. Meredith AM et al. J Am Coll Cardiol 2014;64:1339&ndash;48. &nbsp; El reemplazo valvular a&oacute;rtico transcat&eacute;ter (TAVR) mostr&oacute; resultados comparables a la cirug&iacute;a en pacientes de alto riesgo<a href="https://solaci.org/2015/01/29/n-4940/" title="Read more" >...</a>

Ecocardiografista&nbsp;Fundaci&oacute;n Favaloro. Buenos Aires, Argentina. Recientemente se public&oacute; en JACC Cardiovascular Imaging una evaluaci&oacute;n retrospectiva donde se incluyeron pacientes con estenosis a&oacute;rtica severa (&lt; 1 cm&sup2;), bajo gradiente medio (gradiente medio a&oacute;rtico Los pacientes seleccionados fueron aquellos a los que se le realiz&oacute; un eco estr&eacute;s con dobutamina (EstresDBT) para descartar pseudoestenosis a&oacute;rtica (n=49). El<a href="https://solaci.org/2014/12/18/n-4863/" title="Read more" >...</a>

T&iacute;tulo original: Impact of wait times on the effectiveness of transcatheter aortic-valve replacement (TAVR) in severe aortic valve disease: a discrete event simulation model. Referencia: Wijeysundera HC et al. Can J Cardiol. 2014; Epub ahead of print. &nbsp; Una vez que los pacientes son aceptados para reemplazo valvular a&oacute;rtico percut&aacute;neo (TAVR), cuanto mayor es la<a href="https://solaci.org/2014/06/17/n-4527/" title="Read more" >...</a>

T&iacute;tulo original: The impact of live transmition on patients outcomes during transcatheter aortic valve replacement: Results fron the VERITAS study. Referencia: Ron Waskman, et al. Cardiovascular Revascularization Medicine 2014;15:63-68 &nbsp; &nbsp; Con el avance de la tecnolog&iacute;a m&eacute;dica y el gran desarrollo de las telecomunicaciones, la realizaci&oacute;n de casos en vivo o editados se ha<a href="https://solaci.org/2014/04/11/n-4394/" title="Read more" >...</a>

T&iacute;tulo original: Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis. Referencia: David H. Adams et al. N Engl J Med. 2014 Mar 29. [Epub ahead of print]. &nbsp; El reemplazo valvular a&oacute;rtico trans cat&eacute;ter (TAVR) con la v&aacute;lvula bal&oacute;n expandible mostr&oacute; mejorar la sobrevida en pacientes inoperables y ser similar a la cirug&iacute;a en pacientes de<a href="https://solaci.org/2014/04/09/n-4387/" title="Read more" >...</a>

Titulo original: Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). Referencia: Lindman BR et al. J Am Coll Cardiol. 2014 Mar 25;63(11):1090-9. &nbsp; La diabetes se asocia a una mayor morbilidad y mortalidad<a href="https://solaci.org/2014/03/26/n-4366/" title="Read more" >...</a>

T&iacute;tulo original: Comparison of Results of Transcatheter Aortic Valve Implantation in Patients with Severely Stenotic Bicuspid versus Tricuspid or Non-Bicuspid Valves. Referencia: Charis Costopoulos et al. Am J Cardiol. 2014 Jan 31. pii: S0002-9149(14)00554-2. &nbsp; La v&aacute;lvula bic&uacute;spide es la anomal&iacute;a cong&eacute;nita de la v&aacute;lvula a&oacute;rtica m&aacute;s frecuente con una incidencia aproximada del 1% en<a href="https://solaci.org/2014/03/11/n-4324/" title="Read more" >...</a>

T&iacute;tulo original: Post-procedural aortic regurgitation in balloon-expandable and self-expandable TAVR procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE 2 registry. Referencia: Van Belle E et al. Circulation. 2014; Epub ahead of print. &nbsp; Este trabajo evalu&oacute; con ecocardiograma transtor&aacute;cico 2769 pacientes que recibieron un reemplazo valvular a&oacute;rtico percut&aacute;neo exitoso en<a href="https://solaci.org/2014/03/06/n-4310/" title="Read more" >...</a>